Keywords: basis, lamivudine, efficacy, further, support, use, glaxo

Basis For Lamivudine Efficacy

Article | 29 July 1996

Print This

- Further support for the use of Glaxo Wellcome/BioChem Pharma's Epivir/ 3TC (lamivudine) as a basis for combination therapy was ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in